Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality | Zendy

Hirokazu Honda | Zendy; Abdul Rashid Qureshi | Zendy; Jonas Axelsson | Zendy; Olof Heimbürger | Zendy; Mohamed E. Suliman | Zendy; Peter Bárány | Zendy; Peter Stenvinkel | Zendy; Bengt Lindholm | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Obese sarcopenia in patients with end-stage renal disease is associated with inflammation and increased mortality

Author(s) -

Hirokazu Honda,

Abdul Rashid Qureshi,

Jonas Axelsson,

Olof Heimbürger,

Mohamed E. Suliman,

Peter Bárány,

Peter Stenvinkel,

Bengt Lindholm

Publication year - 2007

Publication title -

american journal of clinical nutrition

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.608

H-Index - 336

eISSN - 1938-3207

pISSN - 0002-9165

DOI - 10.1093/ajcn/86.3.633

Subject(s) - overweight , medicine , body mass index , dialysis , end stage renal disease , wasting , sarcopenia , obesity , hemodialysis , gastroenterology

Adipose tissue in overweight patients with end-stage renal disease (ESRD) is a source of proinflammatory mediators, which could contribute to protein-energy wasting (PEW), cardiovascular disease, and increased mortality. Overweight in ESRD patients, however, is reported to be associated with better survival.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research